Cargando…
Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime
The release of inflammatory bacterial products, such as lipopolysaccharide (LPS)/endotoxin, may be increased upon the administration of antibiotics. An improved quantitative understanding of endotoxin release and its relation to antibiotic exposure and bacterial growth/killing may be gained by an in...
Autores principales: | Thorsted, Anders, Tano, Eva, Kaivonen, Kia, Sjölin, Jan, Friberg, Lena E., Nielsen, Elisabet I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179275/ https://www.ncbi.nlm.nih.gov/pubmed/31988100 http://dx.doi.org/10.1128/AAC.02070-19 |
Ejemplares similares
-
A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6
por: Thorsted, Anders, et al.
Publicado: (2019) -
Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock
por: Goscinski, Gunilla, et al.
Publicado: (2004) -
Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis
por: Rimmler, Christer, et al.
Publicado: (2019) -
Bioequivalence and Population Pharmacokinetic Modeling of Two Forms of Antibiotic, Cefuroxime Lysine and Cefuroxime Sodium, after Intravenous Infusion in Beagle Dogs
por: Zhao, Longshan, et al.
Publicado: (2012) -
Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response
por: Bender, Brendan C, et al.
Publicado: (2015)